← Back to Search

Colorectal Cancer Screening Program for Colorectal Cancer

N/A

Waitlist Available

Led By Roshan Bastani

Research Sponsored by Jonsson Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

PATIENTS: 50-75 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 years

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to increase CRC screening rates in minority & low-income groups with a tailored program & FIT test to detect signs of CRC sooner.

Who is the study for?

This trial is for low-income and ethnic minority individuals aged 50-75 who have visited a clinic at least once in the past two years. It aims to increase colorectal cancer screening rates within these groups.

What is being tested?

The study tests a culturally-tailored program that includes educational interventions, text message reminders, feedback, and fecal immunochemical testing (FIT) to improve colorectal cancer screening among eligible patients.

What are the potential side effects?

Since this trial focuses on education and screening rather than medication or invasive procedures, there are no direct side effects from the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 50 and 75 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Colorectal cancer (CRC) screening rate

Rate of failure to provide a FIT kit to an eligible patient making a clinic visit

Return rate of completed FIT kits

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group I (education, feedback, consult, FIT kit, text message)Experimental Treatment8 Interventions

Physicians and clinic staff receive ongoing training, education, and feedback on CRC screening, and utilize point-of-care clinical decision support tool throughout the trial. Patients receive CRC screening recommendations from provider, a FIT kit with culturally tailored instructions, consultation with clinic staff, and text message reminders throughout the trial.

Group II: Arm II (usual care)Active Control2 Interventions

Physicians and clinic staff provide and patients receive CRC screening usual care throughout the trial.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Health Education

2014

Completed Phase 3

~4410

Feedback

2018